// App-Quantinova.ai

: Real-world treatment patterns and outcomes up to 1 year among children aged <12 years with moderate-to-severe atopic dermatitis (AD) enrolled in the PEDIatric STudy in Atopic Dermatitis (PEDISTAD) observational study

Researchers

Presenter

  • Eulalia Baselga

Principal Investigators

  • Nikolay Murashkin

  • Myong Soon Sung

  • Lara Wine Lee

  • Chunyuan Liu

  • Lauren Bates

  • Annie Zhang

Medical Centers

  • Hospital Sant Joan de Deu de Barcelona, Barcelona, Spain

  • I.M. Sechenov First Moscow State Medical University, Moscow, Russia

  • Inha University Hospital, South Korea

  • Medcl Univ of South Carolina, Charleston, SC

  • Tigermed-BDM, Frederick, MD, USA

  • Regeneron Pharmaceuticals, Inc., Tarrytown, NY

  • Sanofi Genzyme, Cambridge, USA

Locations

  • Spain

  • United States

  • United Kingdom

  • Japan

  • Russia

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

Disease

  • Atopic Dermatitis

Biomarkers

  • N/A

Drug/Treatment

  • Cyclosporine eent

  • Methotrexate

  • Dupilumab

Outcome

  • N/A

Study Design

  • Observational

  • Non Interventional

  • Multinational

  • Controlled

Phase

  • N/A

Study Id's

  • NCT03687359

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved